
|Articles|November 29, 2022
VIDA Launches VIDA Intelligence Portal 2.0
Represents major upgrade of cloud native, AI-enabled Intelligence platform.
Advertisement
VIDA has announced the availability of VIDA Intelligence Portal 2.0, a major upgrade of its cloud native, AI-enabled Intelligence platform. The newly updated platform offers staff training, image data collection and data quality, curation and management.
Read more about the platform upgrade
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
3
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
4
Using AI and Tokenized Data to Match Patients to Protocols
5






.png)



.png)



.png)
.png)
